Short-term risk of colorectal cancer in individuals with lynch syndrome: A meta-analysis

Journal of Clinical Oncology

Volumn 33, Issue 4, 2015, Pages 326-331

  Jenkins, Mark A ^a   Dowty, James G ^a   Ouakrim, Driss Ait ^a   Mathews, John D ^a   Hopper, John L ^a,b   Drouet, Youenn ^c,d   Lasset, Christine ^c,d   Bonadona, Valérie ^c,d   Win, Aung Ko ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Seoul National University   (South Korea)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; GENE MUTATION; GROUPS BY AGE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HUMAN; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; ADULT; AGE; AGED; COLORECTAL NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; MUTATION; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TIME;

MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGE FACTORS; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 84921913628     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.8536     Document Type: Article

References (19)

1. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004
2. Jass JR: Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term. World J Gastroenterol 12:4943-4950, 2006
3. Hampel H, de la Chapelle A: The search for unaffected individuals with Lynch syndrome: Do the ends justify the means? Cancer Prev Res 4:1-5, 2011
4. Dunlop MG, Farrington SM, Nicholl I, et al: Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 83:1643-1645, 2000
5. Thompson BA, Spurdle AB, Plazzer JP, et al: Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 46:107-115, 2013
6. Järvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000
7. Lindor NM, Petersen GM, Hadley DW, et al: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. JAMA 296:1507-1517, 2006
8. Vasen HF, Blanco I, Aktan-Collan K, et al: Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts. Gut 62:812-823, 2013
9. StataCorp: Stata Statistical Software: Release 13. College Station, TX, StataCorp LP, 2013
10. Bonadona V, Bonaïti B, Olschwang S, et al: Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305:2304-2310, 2011
11. Stoffel E, Mukherjee B, Raymond VM, et al: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137:1621-1627, 2009
12. Curado MP, Edwards B, Shin HR, et al: Cancer Incidence in Five Continents, Vol. IX, IARC Scientific Publications No. 160. Lyon, France, International Agency for Research on Cancer, 2007
13. Dowty JG, Win AK, Buchanan DD, et al: Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 34:490-497, 2013
14. Ko CW, Dominitz JA: Complications of colonoscopy: Magnitude and management. Gastrointest Endosc Clin N Am 20:659-671, 2010
15. Jenkins MA, Baglietto L, Dowty JG, et al: Cancer risks for mismatch repair gene mutation carriers: A population-based early onset case-family study. Clin Gastroenterol Hepatol 4:489-498, 2006
16. Choi YH, Cotterchio M, McKeown-Eyssen G, et al: Penetrance of colorectal cancer among MLH1/ MSH2 carriers participating in the colorectal cancer familial registry in Ontario. Hered Cancer Clin Pract 7:14, 2009
17. Quehenberger F, Vasen HF, van Houwelingen HC: Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment. J Med Genet 42:491-496, 2005
18. Rijcken FE, Hollema H, Kleibeuker JH: Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 50:382-386, 2002
19. Dove-Edwin I, Sasieni P, Adams J, et al: Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 331:1047, 2005